Bavarian Nordic Logo

Bavarian Nordic

A biotech firm developing and manufacturing life-saving vaccines for travel and public health.

BAVA | CO

Overview

Corporate Details

ISIN(s):
DK0015998017 (+1 more)
LEI:
2138006JCDVYIN6INP51
Country:
Denmark
Address:
PHILIP HEYMANS ALLE 3, 2900 HELLERUP
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bavarian Nordic is a fully integrated biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The company specializes in preventing infectious diseases through innovative vaccine technologies. It serves as a leading global provider of travel vaccines and is a key partner for governments and international organizations in delivering public health solutions. Bavarian Nordic manages the entire product lifecycle, from initial research and development through to large-scale manufacturing and distribution.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-04 08:30
Major Shareholding Notification
Danish 2.8 KB
2025-11-04 08:30
Major Shareholding Notification
Danish 112.2 KB
2025-11-04 08:30
Major Shareholding Notification
English 188.3 KB
2025-11-04 08:30
Major Shareholding Notification
English 2.9 KB
2025-10-31 15:56
Major Shareholding Notification
English 188.4 KB
2025-10-31 15:56
Major Shareholding Notification
Danish 112.4 KB
2025-10-31 15:56
Major Shareholding Notification
English 2.9 KB
2025-10-31 15:56
Major Shareholding Notification
Danish 2.8 KB
2025-10-31 14:07
M&A Activity
English 148.1 KB
2025-10-31 14:07
M&A Activity
Danish 19.9 KB
2025-10-31 14:07
M&A Activity
English 158.1 KB
2025-10-31 14:07
M&A Activity
Danish 173.8 KB
2025-10-31 14:07
M&A Activity
English 19.2 KB
2025-10-31 14:07
M&A Activity
Danish 136.4 KB
2025-10-31 09:14
Regulatory News Service
English 7.7 KB

Automate Your Workflow. Get a real-time feed of all Bavarian Nordic filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bavarian Nordic

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bavarian Nordic via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Icure Pharmaceutical Incorporation Logo
Develops transdermal patches for dementia/Parkinson's and offers cosmetic ODM/OBM services.
South Korea 175250
Idorsia Ltd Logo
Develops and commercializes small-molecule medicines for CNS, cardiovascular, and immune disorders.
Switzerland IDIA
IGC Pharma, Inc. Logo
Clinical-stage pharma creating Alzheimer's therapies & AI-powered diagnostics.
United States of America IGC
IL DONG PHARMACEUTICAL CO., LTD. Logo
Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.
South Korea 249420
ILSUNG IS CO., LTD. Logo
Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.
South Korea 003120
ILYANG PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.
South Korea 007570
I-Mab Logo
A clinical-stage biopharma developing immuno-oncology agents and bispecific antibodies for cancer.
United States of America IMAB
ImageneBio, Inc. Logo
A clinical-stage biopharma pioneering therapies for immune & inflammatory diseases.
United States of America IMA
IM Cannabis Corp. Logo
International producer of medical-grade cannabis for patients and providers in Israel and Germany.
United States of America IMCC
Immatics N.V. Logo
Develops T-cell redirecting immunotherapies (ACT & TCR Bispecifics) for solid tumor cancers.
United States of America IMTX

Talk to a Data Expert

Have a question? We'll get back to you promptly.